The effect of entecavir combined with Fuzhenghuayu capsule in the treatment of decompensated cirrhosis patients with HBV infection and its influence on serum inflammatory factors

Wang Liuqing; Li Yajing; Xue Sujuan; Li Sheng-nan; Zhang Guoshun

doi:10.3969/j.issn.1671-6450.2020.10.004

Home>Articles>The effect of entecavir combined with Fuzhenghuayu capsule in the treatment of decompensated cirrhosis patients with HBV infection and its influence on serum inflammatory factors

DOI: 10.3969/j.issn.1671-6450.2020.10.004

The effect of entecavir combined with Fuzhenghuayu capsule in the treatment of decompensated cirrhosis patients with HBV infection and its influence on serum inflammatory factors

Wang Liuqing

Li Yajing

Xue Sujuan

Li Sheng-nan

Zhang Guoshun

Machine-generated Keywords：

Publication Date：2020-10-18

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：5( 985-989 )

Chinese Journal of Difficult and Complicated Cases

ISTIC

ISSN：1671-6450

Year, Vol.(Issue)：2020,19(10)